Stock Track | Progyny Plunges 7.37% After-Hours on Slower Growth Outlook and Client Loss

Stock Track02-27 05:41

Progyny's stock experienced a significant after-hours plunge of 7.37% following the release of its fourth-quarter 2025 earnings and future guidance.

The company reported Q4 revenue of $318.4 million, beating estimates, and full-year 2025 revenue growth of 10%. However, investors reacted negatively to the company's outlook for fiscal year 2026, which projects revenue growth of only 5.1% to 9%, a slowdown from the previous year's pace. Additionally, guidance for the first quarter of 2026 indicates revenue growth of just 2.5%.

The detailed earnings report highlighted the loss of a large client that did not renew for 2025, contributing no revenue in the fourth quarter. The company's pharmacy benefit services segment also saw a revenue decline of 1.1% during the quarter, adding to concerns about future growth prospects.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment